American College of Radiology Imaging Network
ACRIN, in operation since March 1999, is a cooperative group that manages clinical trials of imaging technologies as they relate to cancer. ACRIN both funds and provides a complete infrastructure for multi-institutional clinical trials of imaging and related disciplines applied to cancer with support from the National Cancer Institute. It facilitates the development and implementation of trials, data acquisition and management, Operations Manual design and biostatistical analysis, monitoring and quality assurance, financial management, and reporting of trials results.
American College of Radiology
For more than 75 years, the ACR has been the nation's leading voice for radiology, providing its members with vital education, research, scientific information, and advocacy to continually advance the radiology profession and enhance patient care. Today, the ACR remains focused on advancing the science of radiology and improving the quality of patient care through the latest in continuing education material, programs, and cutting-edge research to guide the future of radiology and patient care.
World Molecular Imaging Society
WMIS is a progressive organization that builds the school of thought, scientific paradigms and clinical practices of Molecular Imaging to advance the growing field of Molecular Medicine. The Society holds an annual conference and programs which focus on education in molecular imaging, from basic science to clinical practice and it interacts with government agencies, foundations and the public to increase their knowledge and awareness of molecular imaging and to gain their support. The Society and its journal are involved in the various technologies of molecular imaging and multimodalities formed by merging together imaging of biological processes with imaging anatomical structures within which these processes take place. This includes such technologies as PET, optical imaging, MRI, SPECT, CT and ultrasound. The primary focus of WMIS is in vivo molecular imaging, as well as in vitro studies that underlie the in vivo approaches.
American Society of Clinical Oncology
ASCO is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. ASCO has more than 23,500 members from over 100 countries. ASCO's membership is composed of clinical oncologists representing all oncology disciplines (medical, surgical, and radiologic oncology) and subspecialties; physicians and health-care professionals participating in approved oncology training programs; oncology nurses; and other health-care practitioners with a predominant interest in oncology.
The Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of nuclear medicine and molecular imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNMMI continues to train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances; provide essential resources for health care practitioners and patients; publish the preeminent peer-reviewed resource in the field of nuclear and molecular imaging-The Journal of Nuclear Medicine
; sponsor research grants, fellowships and awards; and host the premier nuclear medicine conference. SNMMI members have developed-and continue to explore-biological and technological innovations in medicine to look noninvasively into the molecular basis of diseases to benefit patients worldwide.